These chapters of the NCCN Drugs & Biologics Compendium™ were developed directly from the NCCN Clinical Practice Guidelines in Oncology for Breast Cancer.

These guidelines were developed by the following NCCN Breast Cancer Panel Members.

Robert W. Carlson, MD/Chair*
Stanford Comprehensive Cancer Center

D. Craig Allred, MD
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Benjamin O. Anderson, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Harold J. Burstein, MD, PhD
Dana-Farber/Brigham and Women's Cancer Center/Massachusetts General Hospital Cancer Center

W. Bradford Carter, MD
H. Lee Moffitt Cancer Center & Research Institute

Stephen B. Edge, MD
Roswell Park Cancer Institute

William B. Farrar, MD
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute at The Ohio State University

Lori J. Goldstein, MD
Fox Chase Cancer Center

William J. Gradishar, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Daniel F. Hayes, MD
University of Michigan Comprehensive Cancer Center

Clifford A. Hudis, MD
Memorial Sloan-Kettering Cancer Center

Mohammad Jahanzeb, MD*
St. Jude Children's Research Hospital/University of Tennessee Cancer Institute

Krystyna Kiel, MD*
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Britt-Marie Ljung, MD
UCSF Helen Diller Family Comprehensive Cancer Center

Lawrence B. Marks, MD*
Duke Comprehensive Cancer Center

Beryl McCormick, MD*
Memorial Sloan-Kettering Cancer Center

Lisle M. Nabell, MD
University of Alabama at Birmingham Comprehensive Cancer Center

Lori J. Pierce, MD*
University of Michigan Comprehensive Cancer Center

Elizabeth C. Reed, MD
UNMC Eppley Cancer Center at The Nebraska Medical Center

Mary Lou Smith, JD, MBA
Consultant

George Somlo, MD
City of Hope

Richard L. Theriault, DO, MBA
The University of Texas M. D. Anderson Cancer Center

Neal S. Topham, MD*
Fox Chase Cancer Center

John H. Ward, MD*
Huntsman Cancer Institute at the University of Utah

Eric P. Winer, MD
Dana-Farber/Brigham and Women's Cancer Center/Massachusetts General Hospital Cancer Center

Antonio C. Wolff, MD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

*Writing Committee Member

Disclosures for the NCCN Breast Cancer Guidelines Panel

At the beginning of each panel meeting to develop NCCN guidelines, panel members disclosed financial support they have received in the form of research support, advisory committee membership, or speakers' bureau participation. Members of the panel indicated that they have received support from the following: Abbott Laboratories, American Bioscience, American Cancer Society, Amgen, AstraZeneca, Avon, Bayer, Boehringer Ingelheim Worldwide, Breast Cancer Research Foundation, Bristol-Myers Squibb, CALGB Foundation, Celgene, Dendreon, Department of Defense, Eisai, Eli Lilly, Ethicon Endo-Surgery, G.E. Healthcare, Genentech, Genomic Health, GlaxoSmithKline, Glaxo Wellcome, GPC Biotech AG, F. Hoffman-La Roche AG, Immunicon, Inc., Kosan Biosciences, Lance Armstrong Foundation, MedImmune, Millennium, Myriad, NCI, NIH, Novartis, Oncotech, Ortho Biotech, OSI, Pfizer, Precision Therapeutics, Inc., Rhone Pouloc Roher, Inc., Roche, Sanofi-Aventis, Susan G. Komen For The Cure, Taiho Pharmaceuticals, Varian Medical Systems, Veridex, and Wyeth. Some panel members do not accept any support from industry. The panel did not regard any potential conflicts of interest as sufficient reason to disallow participation in panel deliberations by any member.

E-mail

Mark A A Size

	Quick Links
Clinical Practice Guidelines Drugs & Biologics Compendium Chemotherapy Order Templates Educational Events CME/CE Programs For Patients: NCCN.com Find an NCCN Member Institution Clinical Practice Guidelines Find Clinical Trials Permissions Requests Case Manager Training Member Institution Profiles Clinical Practice Guidelines Drugs & Biologics Compendium Permissions Requests Supporters and Exhibitors Oncology Research Program Corporate Council Permissions Requests NCCN Academy NCCN Business Insights, Research & Analytics NCCN Flash Updates NCCN Trends Surveys Permissions Requests